Genomics empowers vaccine makers to tackle shapeshifting bacteria

Dearth of high quality monkeypox guidelines may be hampering care globally
16 August 2022
New study indicates people with current cancer diagnosis may face severe complications from COVID-19
17 August 2022

Genomics empowers vaccine makers to tackle shapeshifting bacteria

A pioneering genomic surveillance study has provided the clearest picture yet of the arms race between Streptococcus pneumoniae, the bacterium responsible for a range of illnesses such as pneumonia and meningitis, and the vaccines designed to protect against the most dominant types. A strain called GPSC10 was found to be a particular threat, due to its increased virulence, ability to transform its structure to evade vaccines and its resistance to several common antibiotics.

Comments are closed.